Cargando…
Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo
BACKGROUND AND PURPOSE: The transcription factor NF-κB orchestrates many pro-inflammatory signals and its inhibition is considered a promising strategy to combat inflammation. Here we report the characterization of the natural product plumericin as a highly potent inhibitor of the NF-κB pathway with...
Autores principales: | Fakhrudin, N, Waltenberger, B, Cabaravdic, M, Atanasov, A G, Malainer, C, Schachner, D, Heiss, E H, Liu, R, Noha, S M, Grzywacz, A M, Mihaly-Bison, J, Awad, E M, Schuster, D, Breuss, J M, Rollinger, J M, Bochkov, V, Stuppner, H, Dirsch, V M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966748/ https://www.ncbi.nlm.nih.gov/pubmed/24329519 http://dx.doi.org/10.1111/bph.12558 |
Ejemplares similares
-
Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylation
por: Heiss, Elke H, et al.
Publicado: (2016) -
Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin
por: Khan, Shafaat Y., et al.
Publicado: (2017) -
Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project
por: Waltenberger, Birgit, et al.
Publicado: (2016) -
Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques
por: Noha, Stefan M., et al.
Publicado: (2011) -
Eurycomalactone Inhibits Expression of Endothelial
Adhesion Molecules at a Post-Transcriptional Level
por: Malainer, Clemens, et al.
Publicado: (2017)